Thursday, April 26, 2018
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at page facebook
2018 Growth, Innovation and Leadership Index for Healthcare Attractiveness (GIL-H Index)
(April 16, 2018)

DUBLIN, April 16, 2018 /PRNewswire/ --

The "Growth, Innovation and Leadership Index for Healthcare Attractiveness (GIL-H Index), 2018" report has been added to's offering.

Research and Markets Logo

Despite global political uncertainties and a subdued economic outlook, 2018 is expected to be promising for the global healthcare industry, supported by implementation of major health policies and initiatives. However, the global surge in drug prices will compel pharmaceutical and biotech companies to focus more on innovation as well as on a more favorable regulatory landscape for improved pricing flexibility to help them gauge the demand for healthcare drugs, devices and services.

Despite seeing slow growth, rich counties are re-emerging; BRICS, the economic powerhouse, has started to fall apart, and new emerging and frontier markets are proving to be resilient. With corporates increasingly challenged by the need to invest in technological advancements and th need to find stable sociopolitical environment in countries, a business expansion decision will not be limited to a country's size.

The GIL-H Index or the Growth, Innovation, and Leadership Index for Healthcare Attractiveness essentially helps identify go-to investment destination using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L) and Healthcare (H) pillars. The growth pillar parameters help companies gauge the economic landscape and living standards of countries. The Innovation pillar captures a country's innovation ecosystem strength and human resource capabilities. The Leadership pillar highlights a government's effectiveness in establishing an enabling business environment for investors. The Healthcare pillar reflects the country's strength in generating demand for the healthcare sector. This index is a generalized model and can be specifically engineered for client growth objectives.

The GIL-100 index evaluates and furnishes composite ranks for 110 countries with a Gross Domestic Product (GDP) at and above $20 billion by giving specific weights to G, I, L, and H indicators. The results have further been analyzed under three altering scenarios by assigning changing weights to each of the pillars. Scenario I puts highest weightage to the H pillar, with the remaining weights distributed between the G, I, and L. Scenario II allocates 95% of the weights between H and G, with weightages of just 5% for I and L. Scenario III assigns highest weights to I followed by L, with G and H.

The altering scenarios are also backed by hypothetical case examples that clearly highlight how the GIL Index results can be leveraged with changing client pressure points. A few country profiles from each region are also provided to highlight country drivers and challenges.

Key Topics Covered:

1. Executive Summary

  • Research Overview-GIL-H Index
  • Research Methodology-GIL-H Index
  • GIL-H Results-Key Emerging Markets, 2018

2. Healthcare Industry Challenges

  • Trends and Opportunities in Healthcare, 2017 and Beyond
  • State of Healthcare 2017
  • The Need for a Country Ranking Framework

3. GIL-H Index Framework and Methodology

  • Proprietary GIL Framework and Introduction to GIL-H Index
  • Country Coverage by Region & GDP Bracket
  • Methodology
  • Using GIL-H Index-A Simple 3-Step Process
  • Indicators Coverage in the GIL-H Index, 2018

4. GIL-H Index Scenario Analysis and Results

  • GIL-H Index Scenario Analysis and Results
  • Results Per Scenario
  • Scenario I Hypothetical
  • Scenario II Hypothetical
  • Scenario III Hypothetical

5. Country Case Studies

  • South Africa
  • Chile
  • India
  • Kazakhstan

6. Conclusion

  • Key Conclusions
  • Legal Disclaimer

7. Appendix

  • Indicators Used in the GIL-H Index 2018
  • Country List, GIL-H Index, 2018
  • Global Results
  • Regional Results-Africa, Americas, Asia-Pacific
  • Regional Results-Central Asia, Eastern Europe, Middle East, Western Europe
  • Global Results by GDP Bracket
  • Global Results
  • Regional Results-Africa, Americas, Asia-Pacific
  • Regional Results-Central Asia, Eastern Europe, Middle East, Western Europe
  • Global Results by GDP Bracket
  • Global Results
  • Regional Results-Africa, Americas, Asia-Pacific
  • Regional Results-Central Asia, Eastern Europe, Middle East, Western Europe
  • Global Results by GDP Bracket
  • List of Exhibits

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Science,Medical,Biology,Business,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Centene Corporation Reports 2018 First Quarter Results And Adjusts 2018 Guidance
  • "The Future of Getting Old" - With Old Age, New Possibilities
  • Analysis of Global "Medical Device & Accessories Market" Scope | Set for Rapid Growth 6.53% of CAGR during 2018 to 2023 | Topmost Players, Top Regional Trend & Segments |
  • Pain Management Device Market Factor Analysis 2018 - Technological and Product Development to Drive the Global Industry by 2023
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases

  • World “Americas Interventional Radiology” Market Competitive Landscape with Phenomenal Growth CAGR 5.12% MRFR Unleashing Market Forecast by 2023
  • Research from Columbia Business School Measures Impact of New Cancer Drugs, Finds Most Significant Reduction in Mortality Rates 5-10 Years After Launch
  • Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines
  • Global Biosensors Market 2018-2027: Rising Geriatric Population and Rapid Incorporation of Biosensing Technologies in Non-Medical Applications
  • "21+ Reasons Why" Showcases Support for Tobacco 21

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines